Although there were some discrepancies in the expression of TUBA1C between tumor stages and grades at the protein and mRNA levels, these differences can be attributed to the small sample sizes of advanced-stage and high-grade ccRCC patients in our clinical cohort. The gene discussed is TUBA1C; the disease is neoplasm.